This signaling pathway may be involved in the selective development or differentiation of αSMA+Grem1+ myofibroblastic CAFs, which are distinct from Islr+αSMA- CAFs, in mouse and human CRC. The gene discussed is GREM1; the disease is colorectal carcinoma.